000 01228 a2200349 4500
005 20250510210719.0
264 0 _c19770630
008 197706s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(77)91262-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHarper, A M
245 0 0 _aMigraine and the blood-brain barrier.
_h[electronic resource]
260 _bLancet (London, England)
_cMay 1977
300 _a1034-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBlood-Brain Barrier
650 0 4 _aCerebrovascular Circulation
_xdrug effects
650 0 4 _aEthylamines
_xadverse effects
650 0 4 _aHumans
650 0 4 _aIschemic Attack, Transient
_xchemically induced
650 0 4 _aMigraine Disorders
_xetiology
650 0 4 _aProstaglandins E
_xadverse effects
650 0 4 _aSerotonin
_xadverse effects
650 0 4 _aTyramine
_xadverse effects
650 0 4 _aVasoconstrictor Agents
_xadverse effects
700 1 _aMacKenzie, E T
700 1 _aMcCulloch, J
700 1 _aPickard, J D
773 0 _tLancet (London, England)
_gvol. 1
_gno. 8020
_gp. 1034-6
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(77)91262-4
_zAvailable from publisher's website
999 _c65738
_d65738